Formulation substitution: a frequently overlooked variable in cardiovascular drug management

Prog Cardiovasc Dis. 2004 Jul-Aug;47(1):3-10. doi: 10.1016/j.pcad.2004.04.002.

Author

James A Reiffel¹

Affiliation

¹ Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, The New York Presbytarian Hospital, New York, NY, USA. jar2@columbia.edu

PMID: 15517512
DOI: 10.1016/j.pcad.2004.04.002

No abstract available

Publication types

Review

MeSH terms

Cardiovascular Agents / chemistry*
Cardiovascular Agents / pharmacokinetics*
Chemistry, Pharmaceutical
Drugs, Generic / chemistry*
Drugs, Generic / pharmacokinetics*
Humans
Therapeutic Equivalency

Substances

Cardiovascular Agents
Drugs, Generic